BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9625389)

  • 1. Energy expenditure and protein metabolism in human immunodeficiency virus infection and cancer cachexia.
    Mulligan K; Bloch AS
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):82-91. PubMed ID: 9625389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy expenditure and wasting in human immunodeficiency virus infection.
    Macallan DC; Noble C; Baldwin C; Jebb SA; Prentice AM; Coward WA; Sawyer MB; McManus TJ; Griffin GE
    N Engl J Med; 1995 Jul; 333(2):83-8. PubMed ID: 7777033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of cancer cachexia: current understanding and areas for future research.
    DeWys WD
    Cancer Res; 1982; 42(2 Suppl):721s-726s. PubMed ID: 7055813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The energetics of wasting diseases.
    Kulstad R; Schoeller DA
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):488-93. PubMed ID: 17563468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated energy expenditure in HIV-infected patients: a mechanistic review.
    Chang E; Sekhar R; Patel S; Balasubramanyam A
    Clin Infect Dis; 2007 Jun; 44(11):1509-17. PubMed ID: 17479951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions.
    Pisters PW; Pearlstone DB
    Crit Rev Clin Lab Sci; 1993; 30(3):223-72. PubMed ID: 8260072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
    Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
    Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise and the treatment of wasting: aging and human immunodeficiency virus infection.
    Evans WJ; Roubenoff R; Shevitz A
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):112-22. PubMed ID: 9625393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy and tissue metabolism in patients with cancer during nutritional support.
    Edström S; Bennegård K; Edén E; Lundholm K
    Arch Otolaryngol; 1982 Nov; 108(11):697-9. PubMed ID: 6814408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.
    Lundholm K; Daneryd P; Körner U; Hyltander A; Bosaeus I
    Int J Oncol; 2004 Mar; 24(3):505-12. PubMed ID: 14767534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer.
    Fearon KC; Hansell DT; Preston T; Plumb JA; Davies J; Shapiro D; Shenkin A; Calman KC; Burns HJ
    Cancer Res; 1988 May; 48(9):2590-5. PubMed ID: 3356019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation.
    Moldawer LL; Sattler FR
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):73-81. PubMed ID: 9482543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of altered metabolism in children with cancer.
    Picton SV
    Int J Cancer Suppl; 1998; 11():62-4. PubMed ID: 9876481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.
    Roubenoff R; Grinspoon S; Skolnik PR; Tchetgen E; Abad L; Spiegelman D; Knox T; Gorbach S
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E138-45. PubMed ID: 12067854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management trends. Resting energy expenditure in the HAART era.
    Shevitz AH
    AIDS Read; 2000 Sep; 10(9):539-44; quiz 557-8. PubMed ID: 11019449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scientific rationale for optimizing nutritional support in cancer.
    Skipworth RJ; Fearon KC
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):371-7. PubMed ID: 17413286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent development in research and management of cancer anorexia-cachexia syndrome].
    Inui A
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic responses to tumour disease and progression: tumour-host interaction.
    Cravo ML; Glória LM; Claro I
    Clin Nutr; 2000 Dec; 19(6):459-65. PubMed ID: 11104599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.